LICART .013 g/1
diclofenac epolamine · SYSTEM · IBSA Pharma Inc.
No Recall History
Plain English
LICART is a system containing diclofenac epolamine at .013 g/1, taken topical. Manufactured by IBSA Pharma Inc..
Key Facts
- Brand Name
- LICART
- Generic Name
- diclofenac epolamine
- NDC Code (Product)
71858-0305- Manufacturer
- IBSA Pharma Inc.
- Strength
- .013 g/1
- Dosage Form
- SYSTEM
- Route
- TOPICAL
- Marketing Status
- Application #
- NDA206976
- Marketing Start
- 09/01/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is LICART used for?
LICART contains diclofenac epolamine. It is a system taken topical. Consult your doctor for specific uses.
Is LICART a controlled substance?
LICART is not classified as a controlled substance by the DEA.
What is the generic name for LICART?
The generic name for LICART is diclofenac epolamine. There are 10 other brand versions of diclofenac epolamine.
What is the NDC code for LICART .013 g/1?
The NDC (National Drug Code) for LICART .013 g/1 is 71858-0305, listed by IBSA Pharma Inc..
Other Diclofenac Brands
See all →- Diclofenac Epolamine.013 g/182347-0405
- diclofenac epolamine.013 g/180425-0364
- Diclofenac Epolamine.013 g/176420-673
- FLECTOR.013 g/171858-0405
- diclofenac epolamine.013 g/176420-409
- Diclofenac Epolamine.013 g/180425-0403
- Diclofenac Epolamine.013 g/185509-1405
- diclofenac epolamine.013 g/183008-036
- Diclox Patch 30CT.013 g/187234-0405
- diclofenac epolamine.013 g/10093-3727
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)